Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Drug-Coated Balloons: Expanding Role in Coronary Intervention
Author(s): Bruno Scheller Added: 1 day ago
EuroPCR 2026 – Prof Bruno Scheller (Saarland University Hospital, Homburg, DE) joins us to explore the evolving role of drug-coated balloons in coronary intervention, discussing the latest trial evidence and how it is shaping clinical practice.Interview Questions:How has the role of DCBs in coronary intervention evolved over recent years?What does the latest trial evidence add to our… View more

Intervention
Drug-coated Balloon Angioplasty in Sri Lanka
Author(s): Yanushka Herath , Judy Ranaweera , Thisal Semina , et al Added: 6 months ago

Intervention

Prevention & Chronic Conditions
ISET 25: Drug Delivery Devices: Paclitaxel Drug-Coated Balloons and Drug-Eluting Stents
Author(s): Marianne Brodmann Added: 1 year ago
ISET 2025 - How have drug delivery devices changed over the years, and what are the novel technologies and therapeutic agents?Dr Marianne Brodmann (Medical University of Graz, AT) joins us onsite at ISET 2025 to discuss the current landscape of drug delivery devices, from paclitaxel drug-coated balloons to drug-eluting stents. Dr Brodmann discusses evolving technologies, including bioresorbable… View more

Intervention

Vascular Disease and Surgery
New Data Supports Prevail DCB's Safety and Efficacy
Author(s): Matthias Götberg Added: 7 months ago
Prof Matthias Götberg (Interventional Cardiologist at Skane University Hospital, Lund, SE) provides an overview of the recent two-year data presented from the SCAAR registry and an overview of the bifurcation subset analysis that was presented at EuroPCR in May 2025.Prof Götberg is a contributor to The Swedish Coronary Angiography and Angioplasty Registry (SCAAR), he discusses the key findings… View more

Intervention
CRT 25: 2Y Outcomes of Prevail Paclitaxel-Coated Balloon VS Contemporary DCB
Author(s): Sacharias Von Koch Added: 1 year ago
CRT 25 - Two-year outcomes of the Prevail paclitaxel-coated balloon show no difference in clinical outcomes compared to other drug-coated balloons (DCBs), suggesting the Prevail DCB is as effective and safe as other contemporary DCB's in a real-world setting. The Prevail DCB was also associated with lower rates of myocardial infarction in the sub-group analysis of patients who also underwent… View more

Intervention
EuroPCR 24: The CAGEFREE II Trial
Author(s): Ling Tao Added: 2 years ago
EuroPCR 2024 — Investigator, Dr Ling Tao joins us to discuss the findings from the CAGEFREE II trial.Compared to drug-eluting stents, drug-coated balloons are associated with faster vessel healing and reduced thrombotic burden, therefore patients treated with DCBs require a less intensive antiplatelet therapy. CAGEFREE II investigated the effectiveness and safety of a tailored one-month DAPT… View more

Intervention
LINC 2025: The EAGLE-Study
Author(s): Naoki Hayakawa Added: 1 year ago
LINC 2025 - Three-year outcomes of drug-coated balloon (DCB) treatment for femoropopliteal (FP) chronic total occlusive (CTO) lesions show low patency rates in patents with multiple independent risk factors for patency loss. However, patients without risk factors achieved acceptable patency rates and clinical outcomes of freedom from clinically driven target lesion revascularization, reoclussion… View more

Intervention

Vascular Disease and Surgery
TCT 24: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty
Author(s): Ulf Teichgräber Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of the trial shows that percutaneous transluminal angioplasty (PTA) with the sirolimus drug coated balloon (DCB) in patients with femoropopliteal artery disease was/was not noninferior to PTA with the paclitaxel DCB.Prof Ulf Teichgräber joins us onsite at TCT Conference to discuss the findings from the sirolimus- vs. paclitaxel-coated balloon… View more

Intervention

Vascular Disease and Surgery
The Hybrid Approach in CAD with Restore® DEB
Author(s): Alfonso Ielasi Added: 1 year ago
In this comprehensive video series, Dr Alfonso Ielasi (IRCCS Ospedale Galeazzi Sant'Ambrogio, IT) delves into the approach of using Restore® Drug-Eluting Balloon (DEB) in treating Coronary Artery Disease (CAD). View more

Intervention
TCT 2024 Late-Breaking Science Collection
Author(s): Dr Wissam A Jaber Added: 1 year ago
Keep informed with our video collection unveiling data from the Transcatheter Cardiovascular Therapeutics Conference in Washington. With expert insights on late-breaking trials and critical findings, you won't want to miss our #TCT24 coverage.For practice-focused reviews of the most anticipated trials, watch our recurring View From the Thoraxcenter series, hosted byProf Nicolas Van Mieghem and Dr… View more

Intervention